263 related articles for article (PubMed ID: 16142410)
1. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
2. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
Murthy S; Born E; Mathur SN; Field FJ
J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.
Wente W; Brenner MB; Zitzer H; Gromada J; Efanov AM
Endocrinology; 2007 Apr; 148(4):1843-9. PubMed ID: 17194744
[TBL] [Abstract][Full Text] [Related]
4. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.
Costet P; Luo Y; Wang N; Tall AR
J Biol Chem; 2000 Sep; 275(36):28240-5. PubMed ID: 10858438
[TBL] [Abstract][Full Text] [Related]
5. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
Sabol SL; Brewer HB; Santamarina-Fojo S
J Lipid Res; 2005 Oct; 46(10):2151-67. PubMed ID: 16024918
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
7. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages.
Huwait EA; Singh NN; Michael DR; Davies TS; Moss JW; Ramji DP
J Cell Biochem; 2015 Sep; 116(9):2032-8. PubMed ID: 25752819
[TBL] [Abstract][Full Text] [Related]
9. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells.
Panzenboeck U; Kratzer I; Sovic A; Wintersperger A; Bernhart E; Hammer A; Malle E; Sattler W
Int J Biochem Cell Biol; 2006; 38(8):1314-29. PubMed ID: 16530456
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid transfer protein is regulated by liver X receptors in vivo.
Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
[TBL] [Abstract][Full Text] [Related]
12. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes.
Kase ET; Andersen B; Nebb HI; Rustan AC; Thoresen GH
Biochim Biophys Acta; 2006 Dec; 1761(12):1515-22. PubMed ID: 17055780
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
14. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
15. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
18. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Laffitte BA; Repa JJ; Joseph SB; Wilpitz DC; Kast HR; Mangelsdorf DJ; Tontonoz P
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):507-12. PubMed ID: 11149950
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
Liu QY; Quinet E; Nambi P
Mol Cell Biochem; 2007 Aug; 302(1-2):203-13. PubMed ID: 17396233
[TBL] [Abstract][Full Text] [Related]
20. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1.
Stefulj J; Panzenboeck U; Becker T; Hirschmugl B; Schweinzer C; Lang I; Marsche G; Sadjak A; Lang U; Desoye G; Wadsack C
Circ Res; 2009 Mar; 104(5):600-8. PubMed ID: 19168441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
